Aperio Group LLC raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 20.4% during the second quarter, Holdings Channel reports. The firm owned 28,817 shares of the company’s stock after buying an additional 4,891 shares during the period. Aperio Group LLC’s holdings in Acadia Healthcare were worth $1,423,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Falcon Point Capital LLC acquired a new position in shares of Acadia Healthcare during the first quarter worth about $16,792,000. Monarch Partners Asset Management LLC purchased a new stake in Acadia Healthcare during the first quarter worth $16,079,000. Jennison Associates LLC raised its stake in Acadia Healthcare by 6.3% in the first quarter. Jennison Associates LLC now owns 885,116 shares of the company’s stock worth $38,591,000 after buying an additional 52,158 shares in the last quarter. Emerald Advisers Inc. PA raised its stake in Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock worth $3,715,000 after buying an additional 1,876 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust purchased a new stake in Acadia Healthcare during the first quarter worth $210,000.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded up 2.77% during mid-day trading on Friday, hitting $52.38. 1,219,461 shares of the stock were exchanged. Acadia Healthcare Company, Inc. has a 52-week low of $32.54 and a 52-week high of $54.73. The firm has a market cap of $4.60 billion, a price-to-earnings ratio of 575.60 and a beta of 1.15. The stock has a 50-day moving average price of $50.30 and a 200 day moving average price of $44.67.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm had revenue of $715.90 million for the quarter, compared to the consensus estimate of $717.38 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. The company’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, equities research analysts expect that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

WARNING: “Aperio Group LLC Acquires 4,891 Shares of Acadia Healthcare Company, Inc. (ACHC)” was first reported by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.dailypolitical.com/2017/08/13/aperio-group-llc-acquires-4891-shares-of-acadia-healthcare-company-inc-achc.html.

A number of analysts have weighed in on the stock. UBS AG restated a “positive” rating and set a $60.00 price objective (up from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Deutsche Bank AG raised their price objective on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Craig Hallum restated a “buy” rating and set a $65.00 price objective (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. BidaskClub lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Acadia Healthcare has a consensus rating of “Buy” and an average price target of $59.21.

In other news, EVP Christopher L. Howard sold 16,762 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total transaction of $879,502.14. Following the transaction, the executive vice president now owns 200,999 shares in the company, valued at $10,546,417.53. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Scott Schwieger sold 2,891 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $52.85, for a total transaction of $152,789.35. Following the transaction, the insider now owns 8,841 shares in the company, valued at approximately $467,246.85. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,136,347 shares of company stock worth $105,383,249. Corporate insiders own 11.10% of the company’s stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.